P3 Health Partners Soars as Insiders Invest in the Company

May 19, 2023

Trending News 🌥️

P3 Health Partners ($NASDAQ:PIII) is an innovative healthcare company that is making waves in the industry. Recently, the company saw a significant surge in its stock value after insiders invested in the company. This news has been met with enthusiasm from investors and the medical community alike, as it signifies the potential and growth of the company. This increase in stock price is indicative of the confidence that people investing in the company have in its potential, especially since it is still relatively new. The recent purchases have demonstrated to other investors that P3 Health Partners has what it takes to succeed in the healthcare market. The company provides a wide range of services including primary care, telemedicine, and virtual care.

P3 Health Partners stands out amongst its competitors by providing quality care without sacrificing convenience and flexibility. The company also prides itself on its customer service, with an easy to use platform and helpful support staff. With renewed investments from insiders and a focus on quality care, the company is well-positioned to become a leader in the healthcare industry. Investors should keep an eye on P3 Health Partners as it continues to make strides towards success.

Share Price

On Wednesday, P3 Health Partners (P3HP) soared as its stock opened at $3.5 and closed at $3.4, a 5.6% rise from its last closing price of $3.2. This was due to insiders investing in the company, which increased the market confidence in P3HP. These investments suggest that the company is in a strong financial position and has good prospects for the future.

This news has seen P3HP stock surge in the market, outperforming many of its competitors. The company’s success is expected to continue and investors seem eager to benefit from its growth. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for PIII. More…

    Total Revenues Net Income Net Margin
    1.08k -268.75 47.3%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for PIII. More…

    Operations Investing Financing
    -121.97 -7.05 26.68
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for PIII. More…

    Total Assets Total Liabilities Book Value Per Share
    867.42 396.38 -0.02
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for PIII are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    93.2% -142.7%
    FCF Margin ROE ROA
    -11.5% -60678.8% -110.8%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale’s analysis of P3 HEALTH PARTNERS’ financials shows that the company has been classified as a ‘rhino’, indicating it has achieved moderate revenue or earnings growth. Taking a closer look at the Star Chart, we can see that P3 HEALTH PARTNERS has a low health score of 1/10 in terms of its cashflows and debt, making it less likely to safely ride out any crisis without the risk of bankruptcy. However, P3 HEALTH PARTNERS is strong in terms of growth, yet weak in asset, dividend, and profitability. Given these factors, we think that investors interested in mid-level growth, such as value investors, may be interested in investing in P3 HEALTH PARTNERS. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    P3 Health Partners Inc is facing stiff competition from its rivals in the healthcare industry. Companies such as Skylight Health Group Inc, DocGo Inc and Agilon Health Inc are all vying for market share in this increasingly competitive landscape. All four companies are making innovative use of technology and healthcare services to provide high quality care to their patients, making competition fierce. With advancements in technology and an emphasis on patient experience, the competition is sure to heat up even more in the coming years.

    – Skylight Health Group Inc ($TSXV:SLHG)

    Skylight Health Group Inc is a health care technology company that specializes in providing digital health solutions to its clients. The company’s mission is to deliver accessible, convenient and quality care to its customers. As of 2023, Skylight Health Group Inc has a market capitalization of 4.58M. Skylight’s Return on Equity (ROE) of -54.94% is an indication of the company’s profitability and performance in the market. This indicates that the company is not making enough profits relative to their equity and investors are not receiving a reasonable return on their investments. The company aims to leverage technology to enhance patient engagement and health outcomes, as well as deliver cost-effective healthcare solutions.

    – DocGo Inc ($NASDAQ:DCGO)

    DocGo Inc is a medical care provider that specializes in providing innovative medical services and solutions to clients across the United States. The company has a market capitalization of 886.7M as of 2023, making it one of the larger companies in its sector. Its Return on Equity (ROE) of 5.08% is indicative of the company’s success, providing investors with a good return on their investment. DocGo’s commitment to innovation and delivering quality service has enabled it to remain competitive in the healthcare industry.

    – Agilon Health Inc ($NYSE:AGL)

    Agilon Health Inc is a healthcare technology company that provides care coordination, analytics, and population health services. The company has a market cap of 9.81B as of 2023, indicating its large size and high value in the healthcare industry. Its return on equity (ROE) of -5.95% indicates how much of its profits are returned to its shareholders as dividends or stock buybacks. This negative value suggests that Agilon Health Inc is not generating enough profits to pay back its investors. Despite this, the company’s large market cap indicates its potential for growth, and its services are highly sought after in the healthcare industry.

    Summary

    P3 Health Partners is a health care company that has seen positive changes in its stock price after insider purchases. Analyzing the company’s financials is key to understanding the potential returns from investing in the stock. Looking at the company’s balance sheet can reveal its assets, liabilities, and cash flows. Analyzing the company’s income statement can reveal the profitability of its business operations, including revenue and expenses. Examining the cash flow of the company is important to understand how much cash is generated from operations.

    Additionally, analyzing the company’s market position and competitive landscape should also be considered.

    Recent Posts

    Leave a Comment